DHR Quote, Financials, Valuation and Earnings

Exact Sciences has a net margin of 16.61% compared to Danaher's net margin of -121.19%. Danaher's return on equity of 7.57% beat Exact Sciences's return on equity of -34.11%.

Danaher has a consensus price target of $264.48, signalling upside risk potential of 45.5%. On the other hand Exact Sciences has an analysts' consensus of $68.47 which suggests that it could grow by 60.92%. Given that Exact Sciences has higher upside potential than Danaher, analysts believe Exact Sciences is more attractive than Danaher.

Danaher has a beta of 0.866, which suggesting that the stock is 13.413% less volatile than S&P 500. In comparison Exact Sciences has a beta of 1.136, suggesting its more volatile than the S&P 500 by 13.608%.

Danaher has a quarterly dividend of $0.32 per share corresponding to a yield of 0.62%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Danaher pays 19.7% of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend. Danaher's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Danaher quarterly revenues are $6.5B, which are larger than Exact Sciences quarterly revenues of $713.4M. Danaher's net income of $1.1B is higher than Exact Sciences's net income of -$864.6M. Notably, Danaher's price-to-earnings ratio is 34.43x while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher is 5.61x versus 2.84x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

Illumina has a net margin of 16.61% compared to Danaher's net margin of 16.94%. Danaher's return on equity of 7.57% beat Illumina's return on equity of -35.09%.

Danaher has a consensus price target of $264.48, signalling upside risk potential of 45.5%. On the other hand Illumina has an analysts' consensus of $129.24 which suggests that it could grow by 74.28%. Given that Illumina has higher upside potential than Danaher, analysts believe Illumina is more attractive than Danaher.

Danaher has a beta of 0.866, which suggesting that the stock is 13.413% less volatile than S&P 500. In comparison Illumina has a beta of 1.376, suggesting its more volatile than the S&P 500 by 37.551%.

Danaher has a quarterly dividend of $0.32 per share corresponding to a yield of 0.62%. Illumina offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Danaher pays 19.7% of its earnings as a dividend. Illumina pays out -- of its earnings as a dividend. Danaher's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Danaher quarterly revenues are $6.5B, which are larger than Illumina quarterly revenues of $1.1B. Danaher's net income of $1.1B is higher than Illumina's net income of $187M. Notably, Danaher's price-to-earnings ratio is 34.43x while Illumina's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher is 5.61x versus 2.70x for Illumina. Usually stocks with elevated PS ratios are considered overvalued.

Labcorp Holdings has a net margin of 16.61% compared to Danaher's net margin of 4.31%. Danaher's return on equity of 7.57% beat Labcorp Holdings's return on equity of 9.29%.

Danaher has a consensus price target of $264.48, signalling upside risk potential of 45.5%. On the other hand Labcorp Holdings has an analysts' consensus of $273.67 which suggests that it could grow by 21.63%. Given that Danaher has higher upside potential than Labcorp Holdings, analysts believe Danaher is more attractive than Labcorp Holdings.

Danaher has a beta of 0.866, which suggesting that the stock is 13.413% less volatile than S&P 500. In comparison Labcorp Holdings has a beta of 0.988, suggesting its less volatile than the S&P 500 by 1.19%.

Danaher has a quarterly dividend of $0.32 per share corresponding to a yield of 0.62%. Labcorp Holdings offers a yield of 1.28% to investors and pays a quarterly dividend of $0.72 per share. Danaher pays 19.7% of its earnings as a dividend. Labcorp Holdings pays out 32.59% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Danaher quarterly revenues are $6.5B, which are larger than Labcorp Holdings quarterly revenues of $3.3B. Danaher's net income of $1.1B is higher than Labcorp Holdings's net income of $143.4M. Notably, Danaher's price-to-earnings ratio is 34.43x while Labcorp Holdings's PE ratio is 25.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher is 5.61x versus 1.46x for Labcorp Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Waters has a net margin of 16.61% compared to Danaher's net margin of 26.52%. Danaher's return on equity of 7.57% beat Waters's return on equity of 43.99%.

Danaher has a consensus price target of $264.48, signalling upside risk potential of 45.5%. On the other hand Waters has an analysts' consensus of $401.94 which suggests that it could grow by 23.7%. Given that Danaher has higher upside potential than Waters, analysts believe Danaher is more attractive than Waters.

Danaher has a beta of 0.866, which suggesting that the stock is 13.413% less volatile than S&P 500. In comparison Waters has a beta of 1.036, suggesting its more volatile than the S&P 500 by 3.583%.

Danaher has a quarterly dividend of $0.32 per share corresponding to a yield of 0.62%. Waters offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Danaher pays 19.7% of its earnings as a dividend. Waters pays out -- of its earnings as a dividend. Danaher's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Danaher quarterly revenues are $6.5B, which are larger than Waters quarterly revenues of $872.7M. Danaher's net income of $1.1B is higher than Waters's net income of $231.4M. Notably, Danaher's price-to-earnings ratio is 34.43x while Waters's PE ratio is 30.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher is 5.61x versus 6.54x for Waters. Usually stocks with elevated PS ratios are considered overvalued.